Steve Schonfeld’s Exagen XGN Stock Holding History

Steve Schonfeld’s Portfolio XGN Stock Details XGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-20,333	Closed	-$61K	–	3060
2026 Q1	$61K	Buy	20,333 +6,912	+52%	+$26.7K	﹤0.01%	1945
2025 Q4	$81.6K	Buy	+13,421	New	+$122K	﹤0.01%	1839

Other funds holding XGN

Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return

NCNMGF

Nano-Cap New Millennium Growth Fund Staten Island, New York $130M AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

FCM

FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

MBAM

Mink Brook Asset Management West Palm Beach, Florida $227M AUM 64.76% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Steve Schonfeld's XGN Position: Q2 2026 in Review

Steve Schonfeld sold out of Exagen (XGN) in Q2 2026, closing a stake of 20,333 shares — an estimated $61K sold.

Steve Schonfeld first reported a position in XGN in Q4 2025 and held it in 2 quarters. The position peaked at $81.6K in Q4 2025. 57 funds tracked by Wall St. Rank hold XGN as of Q2 2026.

Steve Schonfeld reported no remaining Exagen position as of Q2 2026 after selling out during the quarter.
Steve Schonfeld sold 20,333 Exagen shares in Q2 2026, an estimated $61K.
Steve Schonfeld first reported a position in Exagen in Q4 2025 and held it in 2 quarters.
Steve Schonfeld's Exagen position peaked at $81.6K in Q4 2025.
57 funds tracked by Wall St. Rank held Exagen as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.